American Regent releases sodium phosphates injection

American Regent is offering sodium phosphates injection, which is therapeutically equivalent to sodium phosphates.

Sodium phosphates injection, 3 mM P/ml is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions.

[Read more: American Regent intros epinephrine injection]

"An important part of our company's mission is to assist in mitigating shortages and ensuring supply of critical medications whenever possible. To that end, we are pleased to add sodium phosphates injection, USP to our robust line of products that are formulated, filled, and finished at our U.S.-based manufacturing facilities," said Joann Gioia, vice president and chief commercial officer at American Regent.